People: Pacira Biosciences Inc (PCRX.OQ)

PCRX.OQ on NASDAQ Stock Exchange Global Select Market

1:30am IST
Change (% chg)

$-0.58 (-1.43%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Scranton, Richard 

Mr. Richard Scranton is Chief Medical Officer of the company since August 2018. He previously served as our Chief Scientific Officer from June 2017 until August 2018, as our Vice President of Clinical and Scientific Affairs from May 2013 through June 2017 and as our Executive Medical Director from November 2011 to May 2013. He has a Masters Degree in Public Health, Clinical Epidemiology/Clinical Effectiveness from the Harvard School of Public Health and earned his M.D. from the Quillen College of Medicine at East Tennessee State University. He completed his residency in the U.S. Navy and was honorably discharged as lieutenant commander, continuing as an Assistant Professor at Harvard Medical School.

Basic Compensation

Total Annual Compensation, USD 707,692
Restricted Stock Award, USD --
Long-Term Incentive Plans, USD --
All Other, USD 1,558,860
Fiscal Year Total, USD 2,266,550

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --